Answers are grounded in this paper and cite their sources.
Dendrimers are emerging as potential nonviral vectors for the efficient delivery of drugs and nucleic acids to the brain and cancer cells. These polymers are highly branched, 3D macromolecules with modifiable surface functionalities and available internal cavities that make them attractive as delivery systems for drug and gene delivery applications. This article highlights the recent therapeutic advances resulting from the use of dendrimers for brain targeting and cancer treatment.
No takes yet. Share an insight, caveat, or question.
Somani et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: